<- Go home

Added to YB: 2019-12-26

Pitch date: 2019-12-26

SLP [bearish]

Simulations Plus, Inc.

+44.79%

current return

Author Info

No bio for this author

Company Info

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

Market Cap

$516.5M

Pitch Price

$34.72

Price Target

N/A

Dividend

N/A

EV/EBITDA

42.47

P/E

71.31

EV/Sales

6.31

Sector

Health Care Technology

Category

N/A

Show full summary:
SIMULATIONS PLUS INC SLP

A summary for this pitch has not been created yet.

Read full article (0 min)